KalVista Pharmaceuticals, Inc.’s (KALV) Moving Averages Convergence Divergence (MACD) indicator is -0.37, suggesting KalVista Pharmaceuticals, Inc. is a Sell.

KalVista Pharmaceuticals, Inc.’s (KALV) 20-Day exponential moving average is 8.41, while KalVista Pharmaceuticals, Inc.’s (KALV) share price is $8.3, making it a Sell.

KalVista Pharmaceuticals, Inc.’s (KALV) 50-Day exponential moving average is 9.19, while KalVista Pharmaceuticals, Inc.’s (KALV) share price is $8.3, making it a Sell.

Advanced Chart >

KalVista Pharmaceuticals (KALV) Pivot Points

Jan 22, 2025, 10:54 AM

Classic

7.44

7.63

7.94

8.14

8.44

8.64

8.95

Fibonacci

7.63

7.82

7.94

8.14

8.33

8.45

8.64

Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

KalVista Pharmaceuticals (KALV) Moving Averages

Jan 22, 2025, 10:54 AM

MA5

7.87Buy

8.09Buy

MA10

8.19Buy

8.16Buy

MA20

8.37Sell

8.41Sell

MA50

9.25Sell

9.19Sell

MA100

10.41Sell

10.11Sell

MA200

11.36Sell

11.12Sell

KalVista Pharmaceuticals, Inc.’s (KALV) 10-Day exponential moving average is 8.16, while KalVista Pharmaceuticals, Inc.’s (KALV) share price is $8.3, making it a Buy.

KalVista Pharmaceuticals, Inc.’s (KALV) 100-Day exponential moving average is 10.11, while KalVista Pharmaceuticals, Inc.’s (KALV) share price is $8.3, making it a Sell.

KalVista Pharmaceuticals, Inc.’s (KALV) stock price is $8.3 and KalVista Pharmaceuticals, Inc.’s (KALV) 50-day simple moving average is 9.25, creating a Sell signal.

KalVista Pharmaceuticals, Inc.’s (KALV) stock price is $8.3 and KalVista Pharmaceuticals, Inc.’s (KALV) 100-day simple moving average is 10.41, creating a Sell signal.

KalVista Pharmaceuticals, Inc.’s (KALV) stock price is $8.3 and KalVista Pharmaceuticals, Inc.’s (KALV) 200-day simple moving average is 11.36, creating a Sell signal.

KalVista Pharmaceuticals (KALV) Technical Indicators

Jan 22, 2025, 10:54 AM

RSI (14)

45.86

Neutral

STOCH (9,6)

45.67

Neutral

STOCHRSI (14)

45.13

Neutral

MACD (12,26)

-0.37

Sell

ADX (14)

22.75

Neutral

Williams %R

-46.06

Buy

CCI (14)

-15.40

Neutral

ATR (14)

0.48

Ultimate Oscillator

45.18

Neutral

ROC

-6.00

Sell

KalVista Pharmaceuticals, Inc.’s (KALV) Relative Strength Index (RSI) is 45.86, creating a Neutral signal.

KalVista Pharmaceuticals, Inc.’s (KALV) Trend Strength Indicator (ADX) is 22.75, creating a Neutral signal.

KalVista Pharmaceuticals, Inc.’s (KALV) Commodity Channel Index (CCI) is -15.40, creating a Neutral signal.

KalVista Pharmaceuticals, Inc.’s (KALV) Price Rate of Change (ROC) is -6.00, creating a Sell signal.

Technical Analysis Screener >

Technical Analysis Screener.

Customize your technical analysis to fit your
unique trading strategy with a flexible screener

Try it Now!

FAQ

Is KALV a Buy, Hold, or Sell?

Based on KALV’s technical indicators, KALV is a Sell.

What is KALV’s RSI (14)?

KALV’s RSI (14) is 45.86, which suggests KALV is a Neutral.

What is KALV’s MACD?

KALV’s MACD is -0.37, which suggests KALV is a Sell.

What is KALV’s 5-day moving average?

KALV’s 5-day moving average is 7.87, which suggests KALV is a Buy.

What is KALV’s 20-day moving average?

KALV 20-day moving average is 8.37, which suggests KALV is a Sell.

What is KALV’s 50-day moving average?

KALV’s 50-day moving average is 9.25, which suggests KALV is a Sell.

What is KALV’s 200-day moving average?

KALV’s 200-day moving average is 11.36, which suggests KALV is a Sell.

What is KALV’s Williams % R (14)?

KALV’s Williams % R (14) is -46.06, which suggests KALV is a Buy.

What is KALV’s CCI (14)?

KALV’s CCI (14) is -15.40, which suggests KALV is a Neutral.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing